3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
1
Solid Tumours
1
Papillomavirus Infections
1
Interventions
human papillomavirus vaccine, L1 type 16, 18
36
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
19
Papillomavirus Vaccines
16
Vaccines
10
Data Collection
9
Blood Specimen Collection
5
Vaccines, Synthetic
4
artesunic acid
3
artemisinin
3
Engerix-B
3
halofantrine
2
epigallocatechin gallate
2
artenimol
2
Hepatitis A Vaccines
2
GX-188 vaccine
2
Colposcopy
2
ranpirnase
1
fludarabine
1
Viusid
1
Vitamin B 12
1
VP-102
1
VGX-3100
1
Therapies, Investigational
1
Sodium Chloride
1
Pentetic Acid
1
Observation
1
Methods
1
Measles-Mumps-Rubella Vaccine
1
Interleukin-2
1
Injections
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Papillomavirus Infections
×
Carbon-14
×
Clear all
NCT06672653
2024-11-04
PREPAP
MGB Pharma
Phase 1/2
Not yet recruiting
66 enrolled